Investing
Digital health company Thirty Madison recently announced the closing of a $47 million Series B funding round.
The company has established collaborations with several vaccine development companies, including the San Diego-based Arcturus which is running clinical trials in Singapore.
Also: $30 million for Reify Health's clinical trial software, and more than $16 million for mPulse Mobile's AI-supported patient communications.
Noting a spike in demand due to COVID-19, the company predicts that it will reach profitability by early 2021.
The voice recognition company aims to improve quality of life for those with speech and motor disabilities.
The startup said its Care Pathway Management platform has so far been deployed among more than 70 health systems in 12 countries.
Also: Dexcom continues to make strides, while iRhythm Technologies takes a hit in Q2.
The new round was led by European Bank for Reconstruction and Development and Health Capital.
The company said its services are accessible to millions of people through partnerships with over 200 employers, health plans and other strategic partners.
The company's complete blood count analyzer uses artificial intelligence to quickly measure biomarkers from a fingerstick or venous sample.